Aerovate Therapeutics Inc

NASDAQ:AVTE   2:49:09 PM EDT
21.00
-0.18 (-0.85%)
Earnings Announcements

Aerovate Therapeutics Announces Qtrly Loss Per Share $23.80

Published: 08/16/2021 12:33 GMT
Aerovate Therapeutics Inc (AVTE) - Aerovate Therapeutics Announces Second Quarter 2021 Financial Results.
Aerovate Therapeutics Inc- Qtrly Loss per Share $23.80.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.29

More details on our Analysts Page.